FutureFuel Corp is rated a 'Buy' due to its recent positive EBITDA guidance and $22 million in 45Z tax credits, signaling a turnaround from previous net losses. The company's flexible operations allow it to switch quickly between specialty chemicals and biodiesel, reducing exposure to commodity price swings and benefiting from favorable market conditions. The biofuel segment is recovering thanks to rising biodiesel prices and lower feedstock costs, which support margin growth and a return to profitability. With a forward price-to-earnings ratio of 7.45x and improving fundamentals, FutureFuel offers attractive upside potential if current market trends continue.
BMO Capital initiated coverage on Tenet Healthcare with a 'Market Perform' rating, indicating the stock is expected to perform in line with the broader market. The company is forecasted to report a 24.05% increase in Earnings Per Share (EPS) to $4.59...
Jaguar Health (JAGX) surged over 1,150% after the FDA granted fee waivers for its drugs Mytesi and Canalevia-CA1, signaling regulatory support. Greenland Mines (GRML) rose nearly 50% amid growing investor interest linked to U.S.-Greenland security de...
The market experienced a downturn with significant losses among key stocks. New Fortress Energy dropped 24.7% amid ongoing volatility in energy sectors, while Xanadu Quantum Technologies fell 21.7% reflecting sensitivity in quantum stocks to commerci...
Jefferies maintains a Hold rating on Capri Holdings due to uncertainty over a potential takeover. Despite a flat global luxury market, Capri's management expects growth in the second half of 2026, driven by new product launches, increased marketing, ...
WTI crude oil prices fell to a new low of $92.87, testing a critical support zone between $93.59 and $94.74. This area includes the 20-day moving average and a 50% retracement level from the prior advance. If this support breaks, the next target is t...
